A new prescription drug, fluoxetine, has led to a resurgence of flu-like symptoms in the UK

A new flu-related prescription drug has led a resurgence in flu-type symptoms in Britain, prompting the health secretary to declare a nationwide lockdown on the drugs.

Key points:The drug, known as fluoxeterine, was approved by the UK Drugs and Cosmetics Authority in November after the Food Standards Agency approved it for use in EuropeThe drug was first prescribed in Australia in November 2014 and later in Europe and the US in January 2018It was given to over 4,000 patients at the Royal Free Hospital in London and the Royal College of Physicians and Surgeons in Cambridge and has been linked to cases of flu and coughThe medicines maker Roche said it had seen a 30% increase in the number of flu patients in Britain over the last six months, with many taking the drug to combat the virus.

But Dr Andrew Jones, head of research and development at Roche, said he was concerned about its safety, saying it was “an extremely potent medication that has not been shown to be as effective as some of the other drugs being used.”

The drugs maker, which has about 3,000 employees worldwide, said it was taking steps to increase safety measures for the drug, including making changes to how it is administered.

The US has seen an increase in cases of influenza in the last two weeks, which experts say is a symptom of the virus spreading rapidly in the United States and Canada.

A new study has found that flu has caused the rise in cases in Britain.

Dr Jones said the UK had seen an average of two cases of the flu each week for the past six months.

“There has been an increase of about 1,300 people who have had flu in Britain this week,” he said.

“We expect this will continue to rise, with a peak in the next few weeks.”

The first thing we need to do is increase our surveillance and surveillance and then we can plan for the flu.

“The new study, published in the journal JAMA Internal Medicine, found that people in England and Wales had been showing an average increase in flu over the past 12 months of 2.6 per cent, with an average case rate of 25.9 per 1,000 people.

In Scotland, the study found the incidence of flu was rising steadily over the previous two weeks.

Dr Michael Gillett, the chief executive of the National Association of Primary Care Trusts (NAPCT), said that while the rise was concerning, he believed that flu was not the main factor behind the increased cases.”

It’s clear that flu is a major factor,” he told the BBC.”

So we need all the resources we can get to keep the population as healthy as possible.

“That’s why we’ve got the flu pandemic emergency plans in place.

We’ve got to do all we can to make sure people get the right medication.”

A spokeswoman for NHS England said the increase in UK cases was not due to flu and that it was encouraging that there was a “significant” decrease in the risk of flu in England.

The spokeswoman said the numbers of flu cases and hospital admissions were lower than they would have been had there been no pandemic.

“For every 10,000 flu cases the UK now has about 10,800 flu-specific hospital admissions,” she said.

The Department of Health said the Government had taken the necessary action to reduce the risk to the public and ensure the safety of patients, staff and patients.

“Since this pandemic began we have been working closely with healthcare professionals, the public health community and the pharmaceutical industry to provide the best possible information for people, including through the NHS and NHS Trusts,” she added.